InsidersTradesSigma
Browse the full record of transactions filed by Williams Brinkley Ruth, Director. Officer active across 1 companies, notably Travere Therapeutics, Inc.. In total, 3 reports have been published. The latest transaction was filed on 11 May 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations
Ruth Brinkley Williams is a Board Member of Travere Therapeutics, Inc. With experience in the pharmaceutical sector, she plays a key role in the governance of the company. As a Board Member, she participates in strategic decision-making that supports innovation and growth at Travere Therapeutics, Inc.